GENETICO |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - RUB | -.--% |
|
-.--% | -.--% |
| Sales 2019 | 400M 4.47M 352M | Sales 2020 | 360M 4.02M 317M | Capitalization | 0 0 0 |
|---|---|---|---|---|---|
| Net income 2019 | 70M 781K 61.56M | Net income 2020 | -48M -536K -42.21M | EV / Sales 2019 * | - |
| Net cash position 2019 * | - 0 0 | Net cash position 2020 * | - 0 0 | EV / Sales 2020 * | - |
| P/E ratio 2019 * |
-
| P/E ratio 2020 * |
-
| Employees | 113 |
| Yield 2019 * |
-
| Yield 2020 * |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
TsGRM Genetiko PAO is a Russia-based company primarily engaged in provision of medical services. The Company comprises laboratory and production complexes that provide a range of medical genetic services for both doctors and patients. The Company conducts complex genetic diagnostics of hereditary diseases and reproductive disorders. The Company's structure consists of four laboratories: Next-Generation Sequencing (NGS) laboratory; Non-Invasive Prenatal Testing (NIPT) laboratory; Oncogenetics laboratory; and Genotyping laboratory.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| -24.88% | 7.74B | |
| +70.72% | 4.39B | |
| +2.96% | 2.61B | |
| -7.18% | 2.53B | |
| -44.46% | 2.22B | |
| -14.65% | 1.8B | |
| -21.62% | 1.54B | |
| +17.46% | 1.23B | |
| -43.89% | 1.15B |
- Stock Market
- Equities
- GECO Stock
